LYMPHATIC DISEASES
Clinical trials for LYMPHATIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new LYMPHATIC DISEASES trials appear
Sign up with your email to follow new studies for LYMPHATIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells get a navigation system to hunt down lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with Hodgkin lymphoma or cutaneous T-cell lymphoma that has not responded to standard therapy or has returned. The treatment uses a patient's own immune cells (T cells) that are genetically modified to recognize and attack c…
Matched conditions: LYMPHATIC DISEASES
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:56 UTC
-
Engineered immune cells with 'Kill Switch' offer new hope for lymphoma patients
Disease control OngoingThis early-phase study tests a new type of CAR T-cell therapy for people with B-cell lymphoma that has come back or not responded to treatment. The T-cells are engineered to recognize and attack cancer cells, but also include a safety switch that can be activated to reduce severe…
Matched conditions: LYMPHATIC DISEASES
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC